The aim is to provide guidance for the optimisation and harmonisation of the management of patients with RCC across the different countries of Asia, drawing on the evidence provided by both Western and Asian trials.
R. Kanesvaran, V. Gruenwald, A. Wong et al.· ESMO Open· 0 citations
INTRODUCTION
Spread through air spaces (STAS) is an adverse histologic feature in early-stage lung adenocarcinoma (LUAD) incorporated into the ninth edition TNM staging. Despite its clinical significance, the molecular features underlying STAS in stage 1 LUAD remain incompletely characterised.
METHODS
Patients with s...
S. Saw, Meng-Yuan Pang, C. Patteri et al.· British Journal of Cancer· 0 citations
BACKGROUND
Enfortumab vedotin (EV) has transformed treatment for advanced urothelial carcinoma (aUC), but outcomes vary. Machine learning (ML) with explainable artificial intelligence (XAI) may improve survival prediction.
METHODS
Data from 544 aUC patients receiving EV after platinum chemotherapy and immunotherapy (...
K. Sridharan, O. Fiala, G. Sivaramakrishnan et al.· Expert Opinion on Biological...· 0 citations
An ethnicity-based benchmarking analysis of therapeutic outcomes across standard-of-care ICI combination regimens demonstrates consistent clinical efficacy across Asian and Caucasian populations, with no statistically significant or clinically meaningful divergence in ORR or PFS.
D. Khanna, T. Dey, E. Blanchard-Cavagis et al.· The Oncologist· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.